Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 732)
Posted On: 11/04/2022 6:57:17 AM
Post# of 153908
Posted By: KenChowder
This may be old news to many here, but I hadn't noticed the language with which the Complaint for Declaratory and Injunctive Relief begins:

Quote:
CytoDyn brings this Complaint to protect 67 patients with treatment-resistant HIV and 25 patients with non-alcoholic steatohepatitis (a kind of liver disease) that are currently receiving CytoDyn’s drug in clinical trials. The safety of these patients is being threatened by Amarex, the clinical research organization managing the trials under contracts with CytoDyn.



So even the opening salvo is a request to protect patients' safety. From my lofty bastion in my armchair (or, more likely, my couch) I am not allowed to comment on why that would be, but I'd be pleased to hear any savvy explanations.













(6)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site